Early- and late-stage Kaposi's sarcoma-derived cells but not activated endothelial cells can invade de-epidermized dermis
- PMID: 11348455
- DOI: 10.1046/j.1523-1747.2001.01319.x
Early- and late-stage Kaposi's sarcoma-derived cells but not activated endothelial cells can invade de-epidermized dermis
Abstract
Whether Kaposi's sarcoma is a true neoplasm or a reactive endothelial cell outgrowth triggered by inflammatory cytokines remains unclear. In this study, we investigated the differential invasive properties of activated endothelial cells and Kaposi's sarcoma cells in a model of de-epidermized dermis, supplying the cells with matrix barriers similar to those found in vivo. Cells derived from early "patch-stage" and from late "nodular-stage" Kaposi's sarcoma lesions exhibited similar invasive properties, which indicates that cells with an invasive potential are present in the early stages of tumor development. Slow accumulation of the cells into the extracellular matrix, together with a low proliferation index and with expression of anti-apoptotic proteins, suggest that the progression of Kaposi's sarcoma may be related to escape from cell death rather than to increased proliferation. The Kaposi's sarcoma-Y1 cell line, which is tumorigenic in nude mice, also exhibited invasive properties. By contrast to the Kaposi's sarcoma-derived spindle cells, however, which were scattered between the collagen bundles, the Kaposi's sarcoma-Y1 cell population had a higher proliferation index and displayed a multilayer arrangement. Inflammatory cytokines and Kaposi's sarcoma cell supernatant could activate and stimulate the growth of human dermal microvascular endothelial cell, but could not induce their invasion in this model, showing that activated endothelial cells do not fit all the requirements to traverse the various barriers found in the dermal extracellular matrix. These results confer to Kaposi's sarcoma cells a tumor phenotype and suggest that the in vivo dominant endothelial cell population represents a reactive hyperplasia rather than the true tumor process.
Similar articles
-
Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells.J Biol Chem. 2004 Feb 6;279(6):4136-43. doi: 10.1074/jbc.M306824200. Epub 2003 Nov 19. J Biol Chem. 2004. PMID: 14627715
-
Spindle cells and their role in Kaposi's sarcoma.Int J Biochem Cell Biol. 2005 Dec;37(12):2457-65. doi: 10.1016/j.biocel.2005.01.018. Epub 2005 Aug 1. Int J Biochem Cell Biol. 2005. PMID: 16188485 Review.
-
Relationship of factor XIIIa-positive dermal dendrocytes to Kaposi's sarcoma.Arch Pathol Lab Med. 1991 Aug;115(8):791-6. Arch Pathol Lab Med. 1991. PMID: 1713758
-
G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.Nature. 1998 Jan 1;391(6662):86-9. doi: 10.1038/34193. Nature. 1998. PMID: 9422510
-
Phenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaque- and nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature.Br J Dermatol. 2000 Sep;143(3):557-63. doi: 10.1111/j.1365-2133.2000.03709.x. Br J Dermatol. 2000. PMID: 10971329 Review.
Cited by
-
Kaposi's sarcoma-associated herpesvirus infection promotes differentiation and polarization of monocytes into tumor-associated macrophages.Cell Cycle. 2017;16(17):1611-1621. doi: 10.1080/15384101.2017.1356509. Epub 2017 Jul 27. Cell Cycle. 2017. PMID: 28750175 Free PMC article.
-
Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death.J Virol. 2009 Jan;83(2):598-611. doi: 10.1128/JVI.00629-08. Epub 2008 Nov 5. J Virol. 2009. PMID: 18987137 Free PMC article.
-
Cultured Kaposi's sarcoma tumor cells exhibit a chemokine receptor repertoire that does not allow infection by HIV-1.BMC Dermatol. 2001;1:2. doi: 10.1186/1471-5945-1-2. Epub 2001 Jul 24. BMC Dermatol. 2001. PMID: 11518547 Free PMC article.
-
Human herpesvirus 8 viral FLICE-inhibitory protein retards cell proliferation via downregulation of Id2 and Id3 expression.Mol Cell Biochem. 2010 Oct;343(1-2):83-9. doi: 10.1007/s11010-010-0501-y. Epub 2010 May 29. Mol Cell Biochem. 2010. PMID: 20512523
-
The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells.PLoS Pathog. 2013;9(11):e1003737. doi: 10.1371/journal.ppat.1003737. Epub 2013 Nov 7. PLoS Pathog. 2013. PMID: 24244164 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials